Nagata D et al. |
Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer. |
2008 |
Cancer Detect. Prev. |
pmid:18789607
|
Cruz-Orengo L et al. |
Cutaneous nociception evoked by 15-delta PGJ2 via activation of ion channel TRPA1. |
2008 |
Mol Pain |
pmid:18671867
|
Oku H and Umino T |
Molecular characterization of peroxisome proliferator-activated receptors (PPARs) and their gene expression in the differentiating adipocytes of red sea bream Pagrus major. |
2008 |
Comp. Biochem. Physiol. B, Biochem. Mol. Biol. |
pmid:18691667
|
Tonge D et al. |
Enhancement of axonal regeneration by in vitro conditioning and its inhibition by cyclopentenone prostaglandins. |
2008 |
J. Cell. Sci. |
pmid:18650498
|
Kim EH and Surh YJ |
The role of 15-deoxy-delta(12,14)-prostaglandin J(2), an endogenous ligand of peroxisome proliferator-activated receptor gamma, in tumor angiogenesis. |
2008 |
Biochem. Pharmacol. |
pmid:18771658
|
Kim JW et al. |
15-Deoxy-Delta(12,14)-prostaglandin J(2) rescues PC12 cells from H2O2-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2. |
2008 |
Biochem. Pharmacol. |
pmid:18775681
|
Ho TC et al. |
15-deoxy-Delta(12,14)-prostaglandin J2 induces vascular endothelial cell apoptosis through the sequential activation of MAPKS and p53. |
2008 |
J. Biol. Chem. |
pmid:18718914
|
Lian TW et al. |
Fisetin, morin and myricetin attenuate CD36 expression and oxLDL uptake in U937-derived macrophages. |
2008 |
Biochim. Biophys. Acta |
pmid:18662803
|
Jozkowicz A et al. |
15d-PGJ2 upregulates synthesis of IL-8 in endothelial cells through induction of oxidative stress. |
2008 |
Antioxid. Redox Signal. |
pmid:18665800
|
Napimoga MH et al. |
Peroxisome proliferator-activated receptor-gamma ligand, 15-deoxy-Delta12,14-prostaglandin J2, reduces neutrophil migration via a nitric oxide pathway. |
2008 |
J. Immunol. |
pmid:18097063
|
Chen A and Zheng S |
Curcumin inhibits connective tissue growth factor gene expression in activated hepatic stellate cells in vitro by blocking NF-kappaB and ERK signalling. |
2008 |
Br. J. Pharmacol. |
pmid:17965732
|
GarcÃa-Bueno B et al. |
Stress mediators regulate brain prostaglandin synthesis and peroxisome proliferator-activated receptor-gamma activation after stress in rats. |
2008 |
Endocrinology |
pmid:18079203
|
Kuboki S et al. |
Peroxisome proliferator-activated receptor-gamma protects against hepatic ischemia/reperfusion injury in mice. |
2008 |
Hepatology |
pmid:18085707
|
Lutzow YS et al. |
15-Deoxy-Delta12,14-prostaglandin J2 induces chemokine expression, oxidative stress and microfilament reorganization in bovine mammary epithelial cells. |
2008 |
J. Dairy Res. |
pmid:18226310
|
Kerr BJ et al. |
The protective effects of 15-deoxy-delta-(12,14)-prostaglandin J2 in spinal cord injury. |
2008 |
Glia |
pmid:18205174
|
Choi IK et al. |
PPAR-gamma ligand promotes the growth of APC-mutated HT-29 human colon cancer cells in vitro and in vivo. |
2008 |
Invest New Drugs |
pmid:18161004
|
Hounoki H et al. |
Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression. |
2008 |
Bone |
pmid:18242157
|
Kim EH et al. |
15-Deoxy-Delta12,14-prostaglandin J2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells: a potential role of ROS. |
2008 |
Carcinogenesis |
pmid:18192694
|
Hao GH et al. |
Agonists at PPAR-gamma suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts. |
2008 |
Br. J. Pharmacol. |
pmid:18278065
|
Kang MA et al. |
Up-regulation of skeletal muscle LIM protein 1 gene by 25-hydroxycholesterol may mediate morphological changes of rat aortic smooth muscle cells. |
2007 |
Life Sci. |
pmid:17161435
|
Sánchez-Gómez FJ et al. |
Direct evidence for the covalent modification of glutathione-S-transferase P1-1 by electrophilic prostaglandins: implications for enzyme inactivation and cell survival. |
2007 |
Arch. Biochem. Biophys. |
pmid:17169324
|
Kim HY and Kim HS |
Upregulation of MIP-2 (CXCL2) expression by 15-deoxy-Delta(12,14)-prostaglandin J(2) in mouse peritoneal macrophages. |
2007 |
Immunol. Cell Biol. |
pmid:17130903
|
Tanaka Y et al. |
Hepatic ischemia-reperfusion induces renal heme oxygenase-1 via NF-E2-related factor 2 in rats and mice. |
2007 |
Mol. Pharmacol. |
pmid:17151289
|
Da Silva Morais A et al. |
Peroxisome proliferated-activated receptor gamma ligand, Pioglitazone, does not prevent hepatic fibrosis in mice. |
2007 |
Int. J. Mol. Med. |
pmid:17143554
|
Lee JH et al. |
15-deoxy-Delta 12,14-ProstaglandinJ2 regulates dedifferentiation through peroxisome proliferator-activated receptor-gamma-dependent pathway but not COX-2 expression in articular chondrocytes. |
2007 |
J. Korean Med. Sci. |
pmid:17982241
|
Li SJ et al. |
[Effect of peroxisome proliferators-activated receptor gamma ligands on cytotrophoblast invasion in first trimester pregnancy]. |
2007 |
Zhonghua Fu Chan Ke Za Zhi |
pmid:17983488
|
Reyes-Martin P et al. |
Cyclooxygenase-independent inhibition of H2O2-induced cell death by S-ketoprofen in renal cells. |
2007 |
Pharmacol. Res. |
pmid:17291778
|
Li X et al. |
Hypoxia reduces the expression and anti-inflammatory effects of peroxisome proliferator-activated receptor-gamma in human proximal renal tubular cells. |
2007 |
Nephrol. Dial. Transplant. |
pmid:17255125
|
Yang WZ et al. |
[The effect of ligand of peroxisome proliferators-activated receptor gamma 15d-PGJ2 on the proliferation and activation of hepatic stellate cells]. |
2007 |
Zhonghua Gan Zang Bing Za Zhi |
pmid:17362636
|
Kim HJ et al. |
15-deoxy-Delta12,14-prostaglandin J2 inhibits transcriptional activity of estrogen receptor-alpha via covalent modification of DNA-binding domain. |
2007 |
Cancer Res. |
pmid:17363578
|
Fionda C et al. |
15-deoxy-Delta12,14-prostaglandin J2 negatively regulates rankl gene expression in activated T lymphocytes: role of NF-kappaB and early growth response transcription factors. |
2007 |
J. Immunol. |
pmid:17371958
|
Ueki S et al. |
Anti- and proinflammatory effects of 15-deoxy-delta-prostaglandin J2(15d-PGJ2) on human eosinophil functions. |
2007 |
Int. Arch. Allergy Immunol. |
pmid:17541271
|
Engdahl R et al. |
15-Deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) mediates repression of TNF-alpha by decreasing levels of acetylated histone H3 and H4 at its promoter. |
2007 |
Biochem. Biophys. Res. Commun. |
pmid:17532302
|
Fulzele SV et al. |
15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors. |
2007 |
Anticancer Drugs |
pmid:17159504
|
Olmos G et al. |
Accumulation of hypoxia-inducible factor-1alpha through a novel electrophilic, thiol antioxidant-sensitive mechanism. |
2007 |
Cell. Signal. |
pmid:17658243
|
Xiang Z et al. |
15d-PGJ2 induces apoptosis of mouse oligodendrocyte precursor cells. |
2007 |
J Neuroinflammation |
pmid:17634127
|
Lin TH et al. |
PPARgamma inhibits osteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats. |
2007 |
Bone |
pmid:17669705
|
Fionda C et al. |
Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes. |
2007 |
Mol. Pharmacol. |
pmid:17673570
|
Chintalgattu V et al. |
PPAR-gamma agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts. |
2007 |
Cardiovasc. Res. |
pmid:17320065
|
Fournier T et al. |
Involvement of PPARgamma in human trophoblast invasion. |
2007 |
Placenta |
pmid:17321592
|
Mizutani N et al. |
Dose-dependent differential regulation of cytokine secretion from macrophages by fractalkine. |
2007 |
J. Immunol. |
pmid:18025192
|
Kim WJ et al. |
Anti-inflammatory lipid mediator 15d-PGJ2 inhibits translation through inactivation of eIF4A. |
2007 |
EMBO J. |
pmid:18034160
|
Haworth O and Buckley CD |
Resolving the problem of persistence in the switch from acute to chronic inflammation. |
2007 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:18093938
|
Han H et al. |
15-Deoxy-delta 12,14-prostaglandin J2 (15d-PGJ 2) sensitizes human leukemic HL-60 cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through Akt downregulation. |
2007 |
Apoptosis |
pmid:17786557
|
Brunoldi EM et al. |
Cyclopentenone prostaglandin, 15-deoxy-Delta12,14-PGJ2, is metabolized by HepG2 cells via conjugation with glutathione. |
2007 |
Chem. Res. Toxicol. |
pmid:17854155
|
Wu P et al. |
Inflammation pro-resolving potential of 3,4-dihydroxyacetophenone through 15-deoxy-delta12,14-prostaglandin J2 in murine macrophages. |
2007 |
Int. Immunopharmacol. |
pmid:17761349
|
Saito Y et al. |
Protective effects of 15-deoxy-Delta12,14-prostaglandin J2 against glutamate-induced cell death in primary cortical neuron cultures: induction of adaptive response and enhancement of cell tolerance primarily through up-regulation of cellular glutathione. |
2007 |
J. Neurochem. |
pmid:17697048
|
Kondoh K et al. |
Inhibition of estrogen receptor beta-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-Delta(12,14)-prostaglandin J(2)-induced apoptosis in cancer cells. |
2007 |
Exp. Cell Res. |
pmid:17706193
|
Richard CL et al. |
15-Deoxy-delta(12,14)-prostaglandin J(2) down-regulates CXCR4 on carcinoma cells through PPARgamma- and NFkappaB-mediated pathways. |
2007 |
Exp. Cell Res. |
pmid:17707368
|
Kamagata C et al. |
15-deoxy-Delta(12,14)-prostaglandin J2 inhibits G2-M phase progression in human breast cancer cells via the down-regulation of cyclin B1 and survivin expression. |
2007 |
Breast Cancer Res. Treat. |
pmid:17028981
|